05:08 PM EDT, 05/16/2024 (MT Newswires) -- Nikhil Lalwani, Director, President & CEO, on May 14, 2024, sold 16,669 shares in Ani Pharmaceuticals ( ANIP ) for $1,101,821. Following the Form 4 filing with the SEC, Lalwani has control over a total of 377,505 shares of the company, with 377,505 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1023024/000182262924000010/xslF345X03/wk-form4_1715893316.xml